-  - Var. - Volume Denaro17:00:02 Lettera17:00:02 Capitalizzazione di mercato Dividend Y. Rapporto P/E
-RON - -
Fatturato: -
-Quantità in denaro: - -Quantità in lettera: - 117.66 bill.RON - -

Descrizione business

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Bill Anderson
Consiglio di amministrazione
Wolfgang Nickl, Heiko Schipper, Rodrigo Santos, Stefan Oelrich, Julio Triana
Consiglio di sorveglianza
Prof. Dr. Norbert Winkeljohann, Heike Hausfeld, Dr. Paul Achleitner, Horst Baier, André van Broich, Ertharin Cousin, Yasmin Fahimi, Dr. Barbara Gansewendt, Colleen A. Goggins, Francesco Grioli, Frank Löllgen, Kimberly Mathisen, Andrea Sacher, Claudia Schade, Lori Schechter, Dr. Nancy Simonian, Jeffrey Ubben, Heinz Georg Webers, Alberto Weisser, Michael Westmeier, Marianne Maehl
 

Dati aziendali

Name: Bayer AG
Indirizzo: Kaiser-Wilhelm-Allee 1,D-51368 Leverkusen
Telefono: +49-214-30-1
Fax: +49-214-30-81013
E-mail: info@bayer.com
Internet: www.bayer.de
Industria: Commodities
Settore: Chemicals
Sub settore: -
Fine dell'anno finanziario: 31/12
Flottante libero: 68.44%
Data dell'IPO: 01/10/1953

Rapporti con gli investitori

Name: Oliver Maier
IR telefono: +49-214-30-65742
IR Fax: +49-214-30-9665742
IR e-mail: oliver.maier@bayer.com

Company calendar

CW 46 | 12/11/2024 Interim Report 3rd Quarter/9 Months
CW 10 | 05/03/2025 4th Quarter/Annual Report
CW 17 | 25/04/2025 General Shareholder Meeting
CW 20 | 13/05/2025 Interim Report 1st Quarter/3 Months